These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1882607)

  • 1. [The action of ribosomal preparations on nonspecific resistance to bacterial infection and on early tolerance to endotoxic shock].
    Belkin ZP; Levenson VI; Egorova TP
    Zh Mikrobiol Epidemiol Immunobiol; 1991 Apr; (4):47-50. PubMed ID: 1882607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Specificity of the protective action of a ribosomal Shigella vaccine and the absence of activity in the ribosomes from R mutants].
    Levenson VI; Rukhadze EZ; Belkin ZP; Essaulova ME
    Zh Mikrobiol Epidemiol Immunobiol; 1988 Oct; (10):55-9. PubMed ID: 2464261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The isolation and immunologic study of ribosomal preparations from Shigella flexneri].
    Belkin ZP; Egorova TP; Fedosova VG; Balaeva EIa; Lebenson VI
    Zh Mikrobiol Epidemiol Immunobiol; 1989 Aug; (8):28-33. PubMed ID: 2511706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The antigenic and immunogenic properties of the bivalent strain Shigella flexneri-Shigella sonnei 1 No. 200].
    Bondarenko VM; Nikolaeva AI; Marakusha BI; Belova TS
    Zh Mikrobiol Epidemiol Immunobiol; 1995; (6):47-8. PubMed ID: 8553752
    [No Abstract]   [Full Text] [Related]  

  • 5. [Biological properties of a ribosomal vaccine from S. sonnei obtained by polyethylene glycol fractionation].
    Levenson VI; Rukhadze EZ; Fedosova VG; Dzhikidze EK; Stasilevich ZK
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Nov; (11):77-81. PubMed ID: 6395593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mechanism of the nonspecific protective action of Shigella antigens].
    Gorbunova ES; Elkina SI; Belina VB; Chekanova IuI; Vinogradov IV
    Zh Mikrobiol Epidemiol Immunobiol; 1988 May; (5):46-8. PubMed ID: 3046195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and evaluation of a Shigella flexneri 2a and S. sonnei bivalent invasin complex (Invaplex) vaccine.
    Oaks EV; Turbyfill KR
    Vaccine; 2006 Mar; 24(13):2290-301. PubMed ID: 16364513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Radioprotective properties of Shigella antigens].
    Gorbunova ES; Mal'tsev VN; Tiurin EA
    Radiobiologiia; 1981; 21(4):591-4. PubMed ID: 7029609
    [No Abstract]   [Full Text] [Related]  

  • 9. [A protective factor of ribosomal shigellosis vaccine].
    Levenson VI; Rukhadze EZ; Egorova TP; Belkin ZP; Fedosova VG
    Zh Mikrobiol Epidemiol Immunobiol; 1988 Jul; (7):50-4. PubMed ID: 3055762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative analysis of IgG class and subclass and IgA serum response to Shigella sonnei and Shigella flexneri 2a polysaccharides following vaccination with Shigella conjugate vaccines.
    Robin G; Keisari Y; Slepon R; Ashkenazi S; Cohen D
    Vaccine; 1999 Aug; 17(23-24):3109-15. PubMed ID: 10462247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The determination in saliva of IgA antibodies to Shigella ribosomes for the diagnosis of dysentery].
    Salamatova SA; Sukhoroslova LI; Chernokhvostova EV; Levenson VI
    Zh Mikrobiol Epidemiol Immunobiol; 1991 Jun; (6):59-62. PubMed ID: 1887713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Ribosomal dysentery vaccine. II. Biological trials of active protection for guinea pigs and mice].
    Levinson VI; Subbotina IuL
    Zh Mikrobiol Epidemiol Immunobiol; 1978 Jul; (7):81-6. PubMed ID: 358702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective ribosomal preparation from Shigella sonnei as a parenteral candidate vaccine.
    Levenson VI; Egorova TP; Belkin ZP; Fedosova VG; Subbotina JL; Rukhadze EZ; Dzhikidze EK; Stassilevich ZK
    Infect Immun; 1991 Oct; 59(10):3610-8. PubMed ID: 1716612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The inductive immunosuppressive activity of the nonspecific lipopolysaccharide fraction of virulent Shigella sonnei].
    Borisova EV; Borisov VA
    Mikrobiol Z; 1997; 59(1):77-81. PubMed ID: 9172868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of prior infection with virulent Shigella flexneri 2a on the resistance of monkeys to subsequent infection with Shigella sonnei.
    Formal SB; Oaks EV; Olsen RE; Wingfield-Eggleston M; Snoy PJ; Cogan JP
    J Infect Dis; 1991 Sep; 164(3):533-7. PubMed ID: 1869840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antigenic characteristics of a preparation obtained by a non-destructive method from Shigella flexneri and Shigella sonnei].
    Gorbunova ES; Elkina SI; Mashiashvili IIa; Bespalova LA; Romanov VS
    Zh Mikrobiol Epidemiol Immunobiol; 1981 Nov; (11):54-9. PubMed ID: 7034415
    [No Abstract]   [Full Text] [Related]  

  • 17. Stable expression of Shigella sonnei form I O-polysaccharide genes recombineered into the chromosome of live Salmonella oral vaccine vector Ty21a.
    Dharmasena MN; Hanisch BW; Wai TT; Kopecko DJ
    Int J Med Microbiol; 2013 Apr; 303(3):105-13. PubMed ID: 23474241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study of intestinal infections in experiments on monkeys].
    Dzhikidze EK; Kavtaradze KN; Stasilevich ZK; Shaginian SA; Gvazava IS
    Vestn Akad Med Nauk SSSR; 1977; (8):59-65. PubMed ID: 410189
    [No Abstract]   [Full Text] [Related]  

  • 19. Safety and antigenicity of typhoid-Shigella sonnei vaccine (strain 5076-1C).
    Tramont EC; Chung R; Berman S; Keren D; Kapfer C; Formal SB
    J Infect Dis; 1984 Feb; 149(2):133-6. PubMed ID: 6366077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Live vaccines for the prevention of intestinal infections].
    Sergeev VV; Kreynin LS; Lichoded VG; Elkina CU; Zukova LF; Kaverina KG
    Arch Exp Veterinarmed; 1980; 34(1):87-9. PubMed ID: 6998403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.